From: Tuberculosis screening of travelers to higher-incidence countries: A cost-effectiveness analysis
 |  | All costs in 2005 US dollars | |||||
---|---|---|---|---|---|---|---|
 |  | Mexico | Dominican Republic | Haiti | |||
 |  | Annual risk of infection 0.3% | Annual risk of infection 0.8% | Annual risk of infection 2.6% | |||
 |  | US-born | Mexican-born | US-born | Dominican-born | US-born | Haitian-born |
Base case | $161,196 | $143,578 | $102,745 | $65,264 | $36,931 | $21,406 | |
Increase traveler age from 21 years†| to 35 years | $163,779 | $148,268 | $103,993 | $67,644 | $37,482 | $22,651 |
 | to 55 years | $178,237 | $164,591 | $113,168 | $76,263 | $40,989 | $26,537 |
Increase trip duration from 3 months†| to 6 months | $111,832 | $60,889 | $16,787 | $108,476 | $48,731 | $15,261 |
 | to 12 months | $67,592 | $71,720 | $31,427 | $31,217 | $5,426 | $8,554 |
 | to 24 months | $35,872 | $41,050 | $13,622 | $16,510 | Cost saving | $2,740 |
Change isoniazid completion rate from 65%†| to 50% | $208,386 | $185,056 | $132,752 | $84,964 | $48,813 | $29,113 |
 | to 100% | $103,191 | $93,192 | $65,368 | $41,179 | $22,017 | $12,007 |